Forza Innovations Inc. Announces Sustainable Origins Update
SAN DIEGO, CA, April 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forza Innovations Inc. (OTC Pink: FORZ) (the “Company”),...
Day: April 19, 2022
Creative Health Care Management Celebrates National Nurses Week 2022 With a Complimentary Webinar for Nursing and Healthcare Professionals
Bloomington, April 19, 2022 (GLOBE NEWSWIRE) -- Today Creative Health Care Management announced it will celebrate National Nurses Week 2022...
InnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand Hearing Aids & Related Products on BestBuy.com
InnerScope's Subsidiary HearingAssist II Inc. Signs Vendor Agreement with Best Buy to Offer Hearing Aids & Related Products sold in...
Dentsply Sirona Provides Corporate Update
John Groetelaars Named Interim Chief Executive Officer Barbara Bodem Named Interim Chief Financial Officer Company Provides Update on Anticipated First...
Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer
Dr. Curtis succeeds Paul Sekhri, who remains on Board of Directors Reflects company’s focus on advancement of portfolio toward clinical...
USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc.
The name change comes from the strong brand recognition garnered by the company’s flagship product, QHSLab WEST PALM BEACH, FL,...
Sharps Compliance Announces Third Quarter Fiscal 2022 Conference Call and Webcast
HOUSTON, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) announced today that it will release its third...
SCYNEXIS Secures Additional Commercial Insurance Formulary Coverage for BREXAFEMME® (ibrexafungerp tablets), Providing Access to an Estimated 93 Million Commercially-Insured Lives
Advanced first-in-class, one-day oral antifungal treatment, BREXAFEMME is now covered for approximately 55 percent of commercially-insured U.S. patientsJERSEY CITY, N.J.,...
AXIM Biotechnologies CEO Issues Letter to Shareholders
Summary: AXIM places strategic focus on commercializing FDA-cleared Dry Eye Disease (DED) diagnostic systemPlans to address largely underserved DED diagnosis...
Finch Therapeutics Announces Workforce Restructuring to Focus Resources on Key Development Programs
SOMERVILLE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...
Assure Holdings Awarded Intraoperative Neuromonitoring Services Group Purchasing Organization Agreement with Conductiv
DENVER, April 19, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...
CinCor Pharma to Participate in Jefferies Biotech on the Bay Summit
WALTHAM, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) today announced its participation in the Jefferies Biotech on...
Evoke Pharma Announces Approval of GIMOTI® to the Texas Medicaid Preferred Drug List
Market access improves with approximately 5 million people in the Texas Medicaid patient networkSOLANA BEACH, Calif., April 19, 2022 (GLOBE...
PetMeds® Announces Exclusive Partnership with Vetster for Pet Telemedicine
New agreement with the fastest-growing veterinary telehealth and pet-care marketplace provides 24/7 access to over 70,000 veterinarians for PetMeds®’ millions...
TRACON Pharmaceuticals Announces Amended ENVASARC Protocol Approved and Open at all 30 Clinical Sites in the U.S. and U.K.
Expects to Report Results of Independent Data Monitoring Committee (IDMC) Mandated Interim Safety Reviews and Interim Efficacy Review in the...
Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer
Dr. El-Gabry’s extensive leadership experience will be critical to accelerating Akoya’s groundbreaking spatial biomarker research technologies into clinical tools that...
Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors
Accomplished business executive and attorney with diverse industry experience including over 20 years in life sciences and pharma with successful...
Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults
– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin®/ Macrilen™in Europe as the Company plans to pursue...
Freeline Appoints Paul Schneider as Chief Financial Officer
Biotech executive with robust experience in financial and corporate strategy and operational excellence will strengthen the company’s leadership teamLONDON, April...
